Public-registry site landscape for NCT02106650, a Relapsed Peripheral T-Cell Lymphoma study sponsored by Acrotech Biopharma Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02106650 (registry record) |
| Sponsor | Acrotech Biopharma Inc. |
| Condition(s) | Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma |
| Phase | PHASE2 |
| Listed sites | 3 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT02106650 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →